1-218414294-A-G

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_003238.6(TGFB2):​c.510+8962A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.572 in 151,826 control chromosomes in the GnomAD database, including 28,036 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.57 ( 28036 hom., cov: 31)

Consequence

TGFB2
NM_003238.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.23

Publications

9 publications found
Variant links:
Genes affected
TGFB2 (HGNC:11768): (transforming growth factor beta 2) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]
TGFB2 Gene-Disease associations (from GenCC):
  • Loeys-Dietz syndrome 4
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: Unknown, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.868 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003238.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
NM_003238.6
MANE Select
c.510+8962A>G
intron
N/ANP_003229.1P61812-1
TGFB2
NM_001135599.4
c.594+8962A>G
intron
N/ANP_001129071.1P61812-2
TGFB2
NR_138148.2
n.1876+8962A>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
ENST00000366930.9
TSL:1 MANE Select
c.510+8962A>G
intron
N/AENSP00000355897.4P61812-1
TGFB2
ENST00000366929.4
TSL:1
c.594+8962A>G
intron
N/AENSP00000355896.4P61812-2
TGFB2
ENST00000488793.1
TSL:3
n.174+8962A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.571
AC:
86686
AN:
151708
Hom.:
27973
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.875
Gnomad AMI
AF:
0.389
Gnomad AMR
AF:
0.601
Gnomad ASJ
AF:
0.441
Gnomad EAS
AF:
0.738
Gnomad SAS
AF:
0.587
Gnomad FIN
AF:
0.432
Gnomad MID
AF:
0.481
Gnomad NFE
AF:
0.398
Gnomad OTH
AF:
0.551
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.572
AC:
86808
AN:
151826
Hom.:
28036
Cov.:
31
AF XY:
0.574
AC XY:
42594
AN XY:
74160
show subpopulations
African (AFR)
AF:
0.876
AC:
36228
AN:
41378
American (AMR)
AF:
0.601
AC:
9174
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.441
AC:
1530
AN:
3466
East Asian (EAS)
AF:
0.738
AC:
3808
AN:
5158
South Asian (SAS)
AF:
0.586
AC:
2814
AN:
4802
European-Finnish (FIN)
AF:
0.432
AC:
4535
AN:
10502
Middle Eastern (MID)
AF:
0.480
AC:
141
AN:
294
European-Non Finnish (NFE)
AF:
0.398
AC:
27056
AN:
67946
Other (OTH)
AF:
0.553
AC:
1167
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1584
3168
4751
6335
7919
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
708
1416
2124
2832
3540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.466
Hom.:
50351
Bravo
AF:
0.598
Asia WGS
AF:
0.640
AC:
2226
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
18
DANN
Benign
0.61
PhyloP100
1.2
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2000220; hg19: chr1-218587636; API